Cover Image
市場調查報告書

敗血症:全球臨床實驗檢討

Septicaemia Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 322156
出版日期 內容資訊 英文 65 Pages
訂單完成後即時交付
價格
Back to Top
敗血症:全球臨床實驗檢討 Septicaemia Global Clinical Trials Review, H2, 2014
出版日期: 2014年12月31日 內容資訊: 英文 65 Pages
簡介

本報告提供敗血症的臨床實驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床實驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 敗血症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要國家的臨床實驗數量
    • 歐洲的主要5個國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要國家的臨床實驗數量

G7各國臨床實驗數量:感染疾病臨床實驗上敗血症所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染疾病臨床實驗上敗血症所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

敗血症治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Venus Remedies Limited
    • Sanofi
    • Shire Plc
    • Pharmaero ApS
    • Pfizer Inc.
    • Huons Co., Ltd.
    • Curacyte AG
  • 有代表性的研究機關·醫院臨床實驗概要
    • University of Oxford
    • Friedrich-Schiller-Universitat Jena
    • Helsinki University Central Hospital
    • University Hospitals
    • European Commission
    • University of Cologne
    • Samsung Medical Center
    • University Medical Center Freiburg
    • Assistance Publique - Hopitaux de Paris
    • University of California, San Francisco

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2497CTIDB

GlobalData's clinical trial report, "Septicaemia Global Clinical Trials Review, H2, 2014" provides data on the Septicaemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Septicaemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Septicaemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Septicaemia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Septicaemia to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Septicaemia to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Septicaemia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Septicaemia Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Venus Remedies Limited
      • Clinical Trial Overview of Venus Remedies Limited
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Shire Plc
      • Clinical Trial Overview of Shire Plc
      • Pharmaero ApS
      • Clinical Trial Overview of Pharmaero ApS
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Huons Co., Ltd.
      • Clinical Trial Overview of Huons Co., Ltd.
      • Curacyte AG
      • Clinical Trial Overview of Curacyte AG
    • Clinical Trial Overview of Top Institutes / Government
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • Friedrich-Schiller-Universitat Jena
      • Clinical Trial Overview of Friedrich-Schiller-Universitat Jena
      • Helsinki University Central Hospital
      • Clinical Trial Overview of Helsinki University Central Hospital
      • University Hospitals
      • Clinical Trial Overview of University Hospitals
      • European Commission
      • Clinical Trial Overview of European Commission
      • University of Cologne
      • Clinical Trial Overview of University of Cologne
      • Samsung Medical Center
      • Clinical Trial Overview of Samsung Medical Center
      • University Medical Center Freiburg
      • Clinical Trial Overview of University Medical Center Freiburg
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Septicaemia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Septicaemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Septicaemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Septicaemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Septicaemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Septicaemia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Septicaemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Septicaemia to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Septicaemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Septicaemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Septicaemia to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Septicaemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Septicaemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Septicaemia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Septicaemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Septicaemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Septicaemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Septicaemia Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Septicaemia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Septicaemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Septicaemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Septicaemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Septicaemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Septicaemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Venus Remedies Limited, 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmaero ApS, 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Huons Co., Ltd., 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Curacyte AG, 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Friedrich-Schiller-Universitat Jena, 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinki University Central Hospital, 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals, 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by European Commission, 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Freiburg, 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*

List of Figures

  • Septicaemia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Septicaemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Septicaemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Septicaemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Septicaemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Septicaemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Septicaemia to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Septicaemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Septicaemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Septicaemia to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Septicaemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Septicaemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Septicaemia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Septicaemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Septicaemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Septicaemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Septicaemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Septicaemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Septicaemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Septicaemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Septicaemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top